申请人:Adorjan Immanuel
公开号:US20110003808A1
公开(公告)日:2011-01-06
This invention relates to novel octahydroquinolizines for treatment or prevention of diabetes mellitus and its complications, for treatment or prevention of hyperlipidemia, for treatment of diabetic dyslipidemia, for treatment or prevention of the metabolic syndrome, for treatment of diseases related to metabolic dysfunction, for treatment of obesity or obesity-related diseases. The invention also includes pharmaceutical compositions and kits comprising these compounds alone or in combination with other drugs or compounds aiming towards an improved treatment or prevention of the aforementioned diseases or syndromes in humans or animals.
本发明涉及一种新型的八氢喹啉类化合物,用于治疗或预防糖尿病及其并发症、治疗或预防高脂血症、治疗糖尿病性脂质代谢紊乱、治疗或预防代谢综合征、治疗与代谢功能障碍相关的疾病、治疗肥胖或肥胖相关疾病。本发明还包括含有这些化合物的药物组合物和配套试剂盒,单独使用或与其他药物或化合物联合使用,旨在改善人类或动物上述疾病或综合征的治疗或预防效果。